“When it comes to dedication, ICTS is second to none. Our study was in crisis mode. Everything we tried had failed. ICTS developed a novel approach to physician referral that prevented yet another round of adding investigators.”
Project Director, Top 50 Pharmaceutical Company

Go back to Blog

  • March 04 2015

Ken Wallace, ICTS VP of Clinical Operations and President of Clinical Trial Marketing communications was recently featured in an article in PharmaPhorum.